{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:58:44Z","timestamp":1790895524121,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP220102231"],"award-info":[{"award-number":["DP220102231"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.rcsop.2025.100630","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:45:02Z","timestamp":1751388302000},"page":"100630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Not so great expectations: The role of price and name information in the nocebo effect"],"prefix":"10.1016","volume":"19","author":[{"given":"Kiarne","family":"Humphreys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Vignaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritika","family":"Sarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Geers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Faasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rcsop.2025.100630_bb0005","doi-asserted-by":"crossref","DOI":"10.1186\/1743-8462-4-7","article-title":"Generic drug policy in Australia: a community pharmacy perspective","volume":"4","author":"Beecroft","year":"2007","journal-title":"Aust N Z Health Policy"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100630_bb0010","first-page":"13","article-title":"Are generic medications safe and effective?","volume":"48","author":"Howland","year":"2010","journal-title":"J Psychosoc Nurs"},{"key":"10.1016\/j.rcsop.2025.100630_bb0015","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1001\/jama.2008.758","article-title":"Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis","volume":"300","author":"Kesselheim","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100630_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1037\/hea0000282","article-title":"Impact of brand or generic labeling on medication effectiveness and side effects","volume":"35","author":"Faasse","year":"2016","journal-title":"Health Psychol"},{"issue":"139","key":"10.1016\/j.rcsop.2025.100630_bb0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/bs.irn.2018.07.016","article-title":"The power of labeling in Nocebo effects","volume":"II","author":"Faasse","year":"2018","journal-title":"Int Rev Neurobiol Neurobiol Placebo Eff Part"},{"key":"10.1016\/j.rcsop.2025.100630_bb0030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/postgradmedj-2012-131730","article-title":"The nocebo effect: patient expectations and medication side effects","volume":"89","author":"Faasse","year":"2013","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rcsop.2025.100630_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurpub\/cky183","article-title":"The impact of generic labels on the consumption of and adherence to medication: a randomized controlled trial","volume":"29","author":"Goldszmidt","year":"2019","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.rcsop.2025.100630_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PSY.0b013e3182738826","article-title":"The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects","volume":"75","author":"Faasse","year":"2013","journal-title":"Psychosom Med"},{"issue":"5","key":"10.1016\/j.rcsop.2025.100630_bb0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.287.5.622","article-title":"Nonspecific medication side effects and the Nocebo phenomenon","volume":"287","author":"Barsky","year":"2002","journal-title":"JAMA"},{"issue":"February","key":"10.1016\/j.rcsop.2025.100630_bb0050","first-page":"1","article-title":"Nocebo effects in health psychology","author":"Faasse","year":"2019","journal-title":"Aust Psychol"},{"issue":"June","key":"10.1016\/j.rcsop.2025.100630_bb0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fpsyt.2019.00396","article-title":"Experimental assessment of nocebo effects and nocebo side effects: definitions, study design, and implications for psychiatry and beyond","volume":"10","author":"Faasse","year":"2019","journal-title":"Front Psych"},{"key":"10.1016\/j.rcsop.2025.100630_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2022.111083","article-title":"Choice and the nocebo effect: If a little is good, more is better?","volume":"164","author":"Faasse","year":"2023","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.rcsop.2025.100630_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/PSY.0b013e3182294a50","article-title":"The nocebo effect and its relevance for clinical practice","volume":"73","author":"Colloca","year":"2011","journal-title":"Psychosom Med"},{"key":"10.1016\/j.rcsop.2025.100630_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1037\/gpr0000171","article-title":"An analysis of the basic processes of formation and change of placebo expectations","volume":"23","author":"Geers","year":"2019","journal-title":"Rev Gen Psychol"},{"key":"10.1016\/j.rcsop.2025.100630_bb0075","first-page":"216","article-title":"Three perspectives on the placebo response: expectancy, conditioning and meaning","volume":"16","author":"Brody","year":"2000","journal-title":"Adv Mind Body Med"},{"issue":"12","key":"10.1016\/j.rcsop.2025.100630_bb0080","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1037\/hea0000416","article-title":"A systematic review of factors that contribute to nocebo effects","volume":"35","author":"Webster","year":"2016","journal-title":"Health Psychol"},{"key":"10.1016\/j.rcsop.2025.100630_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008915","article-title":"Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review","volume":"5","author":"Colgan","year":"2015","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.rcsop.2025.100630_bb0090","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2923.2007.02791.x","article-title":"A comparison between senior medical students\u2019 and pharmacy pre-registrants\u2019 knowledge and perceptions of generic medicines","volume":"41","author":"Hassali","year":"2007","journal-title":"Med Educ"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100630_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10389-011-0393-7","article-title":"Community pharmacists\u2019 perspectives on generic substitution in Japan","volume":"19","author":"Kobayashi","year":"2011","journal-title":"J Public Health"},{"key":"10.1016\/j.rcsop.2025.100630_bb0100","series-title":"Placebo","first-page":"17","article-title":"Placebo, nocebo, and learning mechanisms","volume":"Vol 225","author":"Colloca","year":"2014"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100630_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-6511-14-1","article-title":"A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study","volume":"14","author":"Dunne","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100630_bb0110","first-page":"385","article-title":"Pharmaceuticals: the new brand arena","volume":"44","author":"Chandler","year":"2002","journal-title":"Int J Mark Res"},{"key":"10.1016\/j.rcsop.2025.100630_bb0115","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1503\/cmaj.109-4864","article-title":"The art and science of naming drugs","volume":"186","author":"Collier","year":"2014","journal-title":"CMAJ"},{"issue":"10","key":"10.1016\/j.rcsop.2025.100630_bb0120","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/1359105314525486","article-title":"The malleable effect of name fluency on pharmaceutical drug perception","volume":"20","author":"Cho","year":"2015","journal-title":"J Health Psychol"},{"issue":"10","key":"10.1016\/j.rcsop.2025.100630_bb0125","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1177\/1359105313488974","article-title":"Fluency of pharmaceutical drug names predicts perceived hazardousness, assumed side effects and willingness to buy","volume":"19","author":"Dohle","year":"2014","journal-title":"J Health Psychol"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100630_bb0130","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1212\/WNL.0000000000001294","article-title":"The pharmacodynamics of placebo: expectation effects of price as a proxy for efficacy","volume":"84","author":"LeWitt","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.rcsop.2025.100630_bb0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/pds.2067","article-title":"Assessing general side effects in clinical trials: reference data from the general population","volume":"20","author":"Rief","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100630_bb0140","first-page":"1934","article-title":"Side-effects of oxytocin in postpartum hemorrhage: a systematic review and meta-analysis","volume":"14","author":"Zeng","year":"2022","journal-title":"Am J Transl Res"},{"issue":"7","key":"10.1016\/j.rcsop.2025.100630_bb0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/abm\/kay071","article-title":"The influence of side effect information framing on Nocebo effects","volume":"53","author":"Faasse","year":"2019","journal-title":"Ann Behav Med"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100630_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005374","article-title":"How common are symptoms? Evidence from a New Zealand national telephone survey","volume":"4","author":"Petrie","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.rcsop.2025.100630_bb0155","first-page":"1","article-title":"Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews","author":"Alberts","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100630_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280472","article-title":"The Treatment Expectation Questionnaire (TEX-Q): Validation of a generic multidimensional scale measuring patients\u2019 treatment expectations. Abe T, ed","volume":"18","author":"Shedden-Mora","year":"2023","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100630_bb0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1037\/0022-0167.48.3.310","article-title":"Social connectedness, dysfunctional interpersonal behaviors, and psychological distress: Testing a mediator model","volume":"48","author":"Lee","year":"2001","journal-title":"J Couns Psychol"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100630_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1123\/jtpe.27.2.167","article-title":"Measuring students perceptions of personal and social responsibility and the relationship to intrinsic motivation in urban physical education","volume":"27","author":"Li","year":"2008","journal-title":"J Teach Phys Educ"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100630_bb0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF02249397","article-title":"Trust and commitment in the United States and Japan","volume":"18","author":"Yamagishi","year":"1994","journal-title":"Motiv Emot"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100630_bb0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/game.1995.1027","article-title":"Trust, reciprocity, and social history","volume":"10","author":"Berg","year":"1995","journal-title":"Games Econ Behav"},{"issue":"5","key":"10.1016\/j.rcsop.2025.100630_bb0185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0269881120926673","article-title":"Acute effects of MDMA on trust, cooperative behaviour and empathy: a double-blind, placebo-controlled experiment","volume":"35","author":"Borissova","year":"2021","journal-title":"J Psychopharmacol (Oxf)"},{"issue":"3","key":"10.1016\/j.rcsop.2025.100630_bb0190","first-page":"653","article-title":"Social distance and other-regarding behavior in dictator games","volume":"86","author":"Hoffman","year":"1996","journal-title":"Am Econ Rev"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100630_bb0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1471082X17715718","article-title":"Extended Poisson\u2013Tweedie: properties and regression models for count data","volume":"18","author":"Bonat","year":"2018","journal-title":"Stat Model"},{"key":"10.1016\/j.rcsop.2025.100630_bb0200","series-title":"Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach","author":"Hayes","year":"2013"},{"key":"10.1016\/j.rcsop.2025.100630_bb0205","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/JPR.S134745","article-title":"A systematic review of sex differences in the placebo and the nocebo effect","volume":"10","author":"Vambheim","year":"2017","journal-title":"J Pain Res"},{"key":"10.1016\/j.rcsop.2025.100630_bb0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnins.2019.00160","article-title":"Does sex\/gender play a role in Placebo and Nocebo effects? Conflicting evidence from clinical trials and experimental studies","volume":"13","author":"Enck","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.rcsop.2025.100630_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2022.111136","article-title":"The influence of video-based social modelling on the nocebo effect","volume":"165","author":"Quinn","year":"2023","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100630_bb0220","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/17437199.2024.2394682","article-title":"The effect of social learning on the nocebo effect: a systematic review and meta-analysis with recommendations for the future","volume":"18","author":"Saunders","year":"2024","journal-title":"Health Psychol Rev"},{"key":"10.1016\/j.rcsop.2025.100630_bb0225","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1037\/hea0000199","article-title":"Seeing is believing: impact of social modeling on placebo and nocebo responding","volume":"34","author":"Faasse","year":"2015","journal-title":"Health Psychol"},{"key":"10.1016\/j.rcsop.2025.100630_bb0230","article-title":"A novel paradigm examining the remote induction of nocebo effects online","volume":"27","author":"Barnes","year":"2023","journal-title":"Health Psychol"},{"key":"10.1016\/j.rcsop.2025.100630_bb0235","article-title":"Practitioner warmth and empathy attenuates the nocebo effect and enhances the placebo effect","author":"Barnes","year":"2023","journal-title":"Appl Psychol Health Well-Being"},{"key":"10.1016\/j.rcsop.2025.100630_bb0240","first-page":"1","article-title":"The relationship between expectancy, anxiety, and the nocebo effect: a systematic review and meta-analysis with recommendations for future research","volume":"7","author":"Rooney","year":"2022","journal-title":"Health Psychol Rev"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100630_bb0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1211\/ijpp.13.4.0004","article-title":"Generic medicines: perceptions of consumers in Melbourne, Australia","volume":"13","author":"Hassali","year":"2005","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100630_bb0250","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/1467-8721.00154","article-title":"Mere exposure: a gateway to the Sublimal","volume":"10","author":"Zajonc","year":"2001","journal-title":"Curr Dir Psychol Sci"},{"key":"10.1016\/j.rcsop.2025.100630_bb0255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11606-006-0074-3","article-title":"What\u2019s in a name? Use of brand versus generic drug names in United States Outpatient Practice","volume":"22","author":"Steinman","year":"2007","journal-title":"JGIM"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100630_bb0260","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s11606-018-4455-1","article-title":"Acetaminophen or Tylenol? A retrospective analysis of medication digital communication practices","volume":"33","author":"Ouyang","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"13","key":"10.1016\/j.rcsop.2025.100630_bb0265","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1001\/jama.300.13.1544","article-title":"News media coverage of medication research","volume":"300","author":"Hochman","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100630_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35124-w","article-title":"Evidence for cognitive placebo and nocebo effects in healthy individuals","volume":"8","author":"Turi","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100630_bb0275","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1056\/NEJMra1907805","article-title":"Placebo and Nocebo effects. Ropper AH, ed","volume":"382","author":"Colloca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rcsop.2025.100630_bb0280","doi-asserted-by":"crossref","DOI":"10.1007\/s12160-016-9867-8","article-title":"Latent inhibition reduces Nocebo Nausea, even without deception","author":"Quinn","year":"2017","journal-title":"Ann Behav Med"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100630_bb0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12160-010-9186-4","article-title":"Patient expectancy and post-chemotherapy nausea: a meta-analysis","volume":"40","author":"Colagiuri","year":"2010","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.rcsop.2025.100630_bb0290","article-title":"Risk factors associated with nocebo effects: a review of reviews","volume":"38","author":"Grosso","year":"2024","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.rcsop.2025.100630_bb0295","first-page":"1","article-title":"National ambulatory medical care survey: 2000 summary","volume":"328","author":"Cherry","year":"2002","journal-title":"Adv Data"},{"issue":"suppl 20","key":"10.1016\/j.rcsop.2025.100630_bb0300","first-page":"15","article-title":"Medically unexplained symptoms in primary care","volume":"59","author":"Katon","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.rcsop.2025.100630_bb0305","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.sapharm.2020.09.014","article-title":"Changing understanding, perceptions, pain relief of and preference for generic medicines with patient education: an experimental intervention study","volume":"17","author":"Kleinst\u00e4uber","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2025.100630_bb0310","doi-asserted-by":"crossref","DOI":"10.1037\/hea0000402","article-title":"Changing perceptions and efficacy of generic medicines: an intervention study","author":"Colgan","year":"2016","journal-title":"Health Psychol"},{"key":"10.1016\/j.rcsop.2025.100630_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/aphw.12575","article-title":"Assessing the longevity of attribute framing in attenuating the nocebo effect to brand and generic medication","author":"Barnes","year":"2024","journal-title":"Appl Psychol Health Well-Being"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266727662500071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266727662500071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:34:13Z","timestamp":1758083653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266727662500071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":63,"alternative-id":["S266727662500071X"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100630","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Not so great expectations: The role of price and name information in the nocebo effect","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100630"}}